Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.13 - Radiology/Staging/Screening
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiology/Staging/Screening
-
+
P1.13-001 - T1 Tumor(≪3cm) with Visceral Pleural Invasion Should Be Classified as T2a in the 8th TNM Classification for Lung Cancer
09:30 - 09:30 | Presenter: Jia-Tao Zhang | Author(s): Wen -Feng Li, J. Lin, Si-Yang Liu, Jin -Ji Yang, X. Yang, Yi-Long Wu, W. Zhong
- Abstract
Loading... -
+
P1.13-002 - New Clinical T Classification Is Associated with Pathological Stage I Invasive Adenocarcinoma with Solid Histologic Subtype
09:30 - 09:30 | Presenter: Yutaka Sawai | Author(s): J. Nitadori, T. Takahashi, K. Kitano, K. Nagayama, M. Anraku, M. Sato, Jun Nakajima
- Abstract
Loading... -
+
P1.13-003 - Recurrence Dynamics in Resected Pathological Stage I Lung Adenocarcinoma Depend on the IASLC/ATS/ERS Histological Subtype
09:30 - 09:30 | Presenter: Yusuke Takahashi | Author(s): Takashi Eguchi, Kay See Tan, Z. Tano, William D Travis, D. Jones, Prasad S. Adusumilli
- Abstract
Loading... -
+
P1.13-004 - The Role of Lymph Node Staging by EBUS-TBNA in Stereotactic Body Radiation Therapy for patients with Non-Small Cell Lung Cancer.
09:30 - 09:30 | Presenter: Kohei Hashimoto | Author(s): N. Daddi, Meredith Elana Giuliani, A.J. Hope, L. Le, K. Czarnecka, M. Cypel, A. Pierre, Marc De Perrot, Gail Elizabeth Darling, T.K. Waddell, S. Keshavjee, Kazuhiro Yasufuku
- Abstract
Loading... -
+
P1.13-005 - Is Tumor Size for the T4 Descriptor in Lung Cancer Staging Appropriate?
09:30 - 09:30 | Presenter: Junji Ichinose | Author(s): Y. Matsuura, Masayuki Nakao, Mingyon Mun, K. Nakagawa, S. Okumura
- Abstract
Loading... -
+
P1.13-006 - The Value of F-18 FDG PET/CT-guided EBUS-TBNA in Nodal Staging of NSCLC.
09:30 - 09:30 | Presenter: Sung Yong Lee | Author(s): S. Lee, D. Lee, K.H. Jung, S. Kim
- Abstract
Loading... -
+
P1.13-007 - Is Central Lung Tumor Location Really Predictive for Occult Mediastinal Nodal Disease in (Suspected) NSCLC Staged cN0 on PET-CT?
09:30 - 09:30 | Presenter: Herbert Decaluwe | Author(s): J. Moons, W. De Wever, C. Deroose, A. Stanzi, L. Depypere, K. Nackaerts, J. Coolen, M. Lambrecht, Dirk K De Ruysscher, Johan F. Vansteenkiste, D. Van Raemdonck, Paul De Leyn, C. Dooms
- Abstract
Loading... -
+
P1.13-008 - Evaluation of Clinical Associated Factors for Lung Adenocarcinoma by TNM 8th Edition with Unexpected N2 disease
09:30 - 09:30 | Presenter: Yoshiteru Kidokoro | Author(s): T. Haruki, W. Fujiwara, T. Ohno, K. Hosoya, Yasuaki Kubouchi, M. Wakahara, Yohei Yurugi, Y. Takagi, K. Miwa, K. Araki, Y. Taniguchi, H. Nakamura
- Abstract
Loading... -
+
P1.13-009 - Macroscopic and Microscopic Lymphatic Remodeling Caused by VEGF-C Play a Key Role in Lymphatic Metastasis of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiromitsu Takizawa
- Abstract
Loading... -
+
P1.13-010 - Is MRI Brain Mandatory in All Patients with Early Stage NSCLC?
09:30 - 09:30 | Presenter: George Karimundackal | Author(s): B. Gangadharan
- Abstract
Loading... -
+
P1.13-011 - Prospective Cohort Study of Patterns of Staging and Treatment Selection with or Without Multidisciplinary (MD) Care
09:30 - 09:30 | Presenter: Raymond Osarogiagbon | Author(s): F.E. Rugless, M.A. Ray, Matthew P Smeltzer, B. Jackson, C. Foust, A. Patel, N. Boateng, N.R. Faris, C. Houston-Harris, C. Fehnel, M. Meadows, K. Roark, L. McHugh, R.S. Signore, E.T. Robbins, R. Fox
- Abstract
Loading... -
+
P1.13-011a - Stratification Based on PET/CT Findings for Malignant Grade of Radiologically Pure Solid Small-Sized (≪ 2cm) Lung Cancer
09:30 - 09:30 | Presenter: Norifumi Tsubokawa | Author(s): Yasuhiro Tsutani, Y. Miyata, H. Hanaki, Norihiko Ikeda, H. Nakayama, Morihito Okada
- Abstract
Loading... -
+
P1.13-011b - Nodal Status Based on the Anatomical Location or the Number of Lymph Nodes Metastasis
09:30 - 09:30 | Presenter: K. Masai | Author(s): S. Omura, M. Suzuki, H. Tanaka, S. Kuriyama, Hiroyuki Sakamaki, Kaoru Kaseda, T. Hishida, Takashi Ohtsuka, Hisao Asamura
- Abstract
Loading... -
+
P1.13-011c - A Study on the Prognosis of Hilar and Interpulmonary Lymph Nodes Patients with Pathologic T1N1M0 and T2N1M0 Disease in NSCLC
09:30 - 09:30 | Presenter: Jun Suzuki | Author(s): H. Oizumi, H. Kato, A. Hamada, K. Nakahashi
- Abstract
Loading... -
+
P1.13-011d - Risk of Pleural Recurrence After Percutaneous Transthoracic Needle Biopsy in Stage I Non-Small Cell Lung Cancer: A Large Center Experience
09:30 - 09:30 | Presenter: Su Yeon Ahn | Author(s): Soon Ho Yoon, Young Tae Kim, Chang Hyun Kang, In Kyu Park, C.M. Park, Jin Mo Goo
- Abstract
Loading...
-
+
P1.14 - Radiotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
P1.14-001 - The Feasibility of Predicting Radiation Pneumonitis Using Lung Equivalent Uniform Dose (LEUD) in Volumetric-Modulated Arc
09:30 - 09:30 | Presenter: Xiadong Li | Author(s): J. Gu, C. Wang, Q. Deng, Shenglin Ma, Y. Ren, L. Xing, T. Niu
- Abstract
Loading... -
+
P1.14-002 - Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumors After Resection of Lung Cancer
09:30 - 09:30 | Presenter: Shigeo Takahashi | Author(s): T. Go, T. Kinoshita, Hiroyasu Yokomise, T. Shibata
- Abstract
Loading... -
+
P1.14-003 - Anesthesia Allows Safe Administration of SBRT for Early Stage Lung Cancer Patients with Advanced Cognitive Impairments
09:30 - 09:30 | Presenter: Gregory M.M. Videtic | Author(s): M.T. Freeman, N. Woody
- Abstract
Loading... -
+
P1.14-004 - Outcomes of Stereotactic Body Radiotherapy and Surgery in Treating Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis
09:30 - 09:30 | Presenter: Liang Wang | Author(s): Y. Pei, S. Li, S. Zhang, Y. Yang
- Abstract
Loading... -
+
P1.14-005 - Development of a Novel Spacer to Reduce Mediastinal Organ Toxicity from Stereotactic Body Radiotherapy
09:30 - 09:30 | Presenter: Yusuke Muranishi | Author(s): T. Sato, M. Tanooka, H. Doi, Y. Yutaka, Y. Sakaguchi, S. Hasegawa, N. Kamikonya, T. Nakamura, H. Date
- Abstract
Loading... -
+
P1.14-006 - Carbon-Ion Radiotherapy for Isolated Lymph Node Metastasis from Lung Cancer Using a Regimen of 12 Fractions during 3 Weeks
09:30 - 09:30 | Presenter: Katsuyuki Shirai | Author(s): J. Saitoh, T. Abe, T. Ohno, T. Nakano
- Abstract
Loading... -
+
P1.14-007 - Mesenchymal Stem Cells Labeled with Fluorescent Magnetic Nanoparticles for Targeted Imaging and Hyperthermia Therapy of Lung Cancer
09:30 - 09:30 | Presenter: Runlei Hu
- Abstract
Loading... -
+
P1.14-008 - Elevated Platelet Levels Affect Prognosis in Patients with NSCLC Treated with Curatively Intended Chemoradiotherapy
09:30 - 09:30 | Presenter: Georg Holgersson | Author(s): S. Bergström, P. Liv, Jonas Nilsson, M. Bergqvist
- Abstract
Loading... -
+
P1.14-009 - Comparison of Dosimetric Parameters and Outcome in Non-Small Cell Lung Cancer Patients Having 3D Conformal or VMAT Plans
09:30 - 09:30 | Presenter: Nur Abdul Satar | Author(s): S. Lynch, P. Wells, S. Bowles, K. Yip, J. Conibear
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.14-013 - High Dose Radiotherapy (74Gy) Improved Local Progression Free Survival in Patients with Inoperable Stage III NSCLC
09:30 - 09:30 | Presenter: Young Il Kim | Author(s): S. Kim, J.S. Kim, M.J. Cho
- Abstract
Loading... -
+
P1.14-014 - Comparative Evaluation of VMAT & 3D-CRT in Locally Advanced NSCLC: Is There Any Radiobiological Advantage?
09:30 - 09:30 | Presenter: Iulian Badragan | Author(s): S. Roy, M. Sia, J. Singh, G. Bahl, S.N. Ahmed
- Abstract
Loading... -
+
P1.14-015 - Local Recurrence Rate and Timing after Stereotactic Body Radiotherapy for Lung Cancer: Need for Long-term Follow-up
09:30 - 09:30 | Presenter: Takashi Shintani | Author(s): Yukinori Matsuo, Takamasa Mitsuyoshi, Y. Iizuka, T. Mizowaki
- Abstract
Loading... -
+
P1.14-016 - Assessing the Feasibility of FLT-PET for Evaluation of Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiotherapy (SBRT)
09:30 - 09:30 | Presenter: Meredith Elana Giuliani | Author(s): H. Raziee, A.J. Hope, Andrea Bezjak, A. Sun, John Cho, J. Bissonnette, D. Vines, B. Driscoll
- Abstract
Loading... -
+
P1.14-017 - Impact of Systematic EBUS-TBNA Mediastinal Staging on Radical Radiotherapy Planning in NSCLC
09:30 - 09:30 | Presenter: Nicholas Hardcastle | Author(s): A.J. Cole, Guy-Anne Turgeon, Roshini Thomas, B. Gearey, L.B. Irving, B.R. Jennings, T. Kron, David L Ball, Daniel P Steinfort, S. Siva
- Abstract
Loading... -
+
P1.14-018 - Construction and Evaluation of RapidPlanTM Models for Radical Lung Planning
09:30 - 09:30 | Presenter: Timothy Mitchell | Author(s): Y. Flanagan, P. Kelso, S. Smith
- Abstract
Loading... -
+
P1.14-018a - Stereotactic Ablative Radiotherapy for Ultra-Central Lung Tumors: Optimize Tumor Control or Minimize Toxicity?
09:30 - 09:30 | Presenter: Alexander Vincent Louie | Author(s): Joanna M Laba, D.H. Murrell, A. Erickson, B. Millman, D.A. Palma
- Abstract
Loading...
-
+
P1.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P1.15-001 - Ipilimumab Increases Th1/Th2 and Inflammatory Cytokines Counteracting Chemotherapy Effects in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Edurne Arriola | Author(s): M. Hardy-Werbin, P. Rocha, O. Arpí, Á. Taus, D. Joseph-Pietras, A. Rovira, J. Albanell, C. Ottensmeier
- Abstract
Loading... -
+
P1.15-002 - A Retrospective Study of Amrubicin Monotherapy for the Treatment of Relapsed Small Cell Lung Cancer in Elderly Patients
09:30 - 09:30 | Presenter: Hiroyuki Minemura | Author(s): Hisao Imai, T. Sugiyama, T. Tamura, K. Kaira, K. Kanazawa, H. Yokouchi, T. Kasai, T. Kaburagi, K. Minato
- Abstract
Loading... -
+
P1.15-003 - Survival by Response to First-line Platinum-Based Therapy Among Patients With Extensive Disease Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yong Yuan | Author(s): M.D. Danese, M. Gleeson, D. Lubeck, J.R. Penrod, B. Korytowsky
- Abstract
Loading... -
+
P1.15-004 - An Open-Label, Multitumor Phase II Basket Study of Olaparib and Durvalumab (MEDIOLA): Results in Patients with Relapsed SCLC
09:30 - 09:30 | Presenter: Matthew G Krebs | Author(s): K. Ross, Sang-We Kim, M. De Jonge, Fabrice Barlesi, S. Postel-Vinay, S.M. Domchek, J. Lee, H.K. Angell, K. Bui, S. Chang, C. Gresty, P. Herbolsheimer, J. Delord
- Abstract
Loading... -
+
P1.15-005 - Relationship Between MYC Family Status and Sensitivity to Aurora Kinase Inhibitors in Neuroendocrine and Other Lung Cancer Cell Lines
09:30 - 09:30 | Presenter: Tomohiro Haruki | Author(s): M. Papari-Zareei, W. Zhang, Y. Zhang, V. Stastny, J. Minna, A.F. Gazdar
- Abstract
Loading... -
+
P1.15-006 - Enriched Environment and Anti-Depressants Enhance Platinum Chemosensitivity of Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Qiming Wang | Author(s): Y. Wu, H. Tang
- Abstract
Loading... -
+
P1.15-007 - Randomized Phase III Trial of Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: The RASTEN Trial
09:30 - 09:30 | Presenter: Emelie Gezelius | Author(s): L. Ek, B. Bergman, P. Bendahl, H. Anderson, U. Falkmer, S. Verma, J. Sundberg, M. Wallberg, M. Belting
- Abstract
Loading... -
+
P1.15-008 - Clinical Features and Gene Mutation Profiling of Pulmonary Carcinoid Tumors
09:30 - 09:30 | Presenter: Xiongfei Li | Author(s): M. Li, Renwang Liu, S. Wei, G. Chen, J. Chen, S. Xu
- Abstract
Loading... -
+
P1.15-009 - Safety and Efficacy of Nab-Paclitaxel Monotherapy as 2nd or Later Line Setting in Pts with Extensive SCLC, a Phase II Single Arm Study (NCT02262897)
09:30 - 09:30 | Presenter: Shengxiang Ren | Author(s): G. Gao, W. Li, X. Chen, Fengying Wu, C. Su, J. Zhao, Y. Sun, Weijing Cai, Caicun Zhou
- Abstract
Loading... -
+
P1.15-010 - Small Cell Lung Cancer: Experience of a Portuguese District Hospital
09:30 - 09:30 | Presenter: Margarida Felizardo | Author(s): C.G.P. Matos, V. Sacramento, J. Passos Coelho, S. Tello Furtado
- Abstract
Loading... -
+
P1.15-011 - Longitudinal Mutation Monitoring in Plasma Without Matching Tumor Tissue by Deep Sequencing in Small Cell Lung Cancer (SCLC)
09:30 - 09:30 | Presenter: André Rosenthal | Author(s): M. Lange, S. Beckert, B. Hinzmann, C. Woestmann, B. Wehnl, M. Schneider, M. Meister, M. Thomas, T. Muley, A. Warth, S. Froehler, J.F. Palma, F.J. Herth
- Abstract
Loading... -
+
P1.15-012 - Clinical Prognostic Factors of Elderly Patients with Extensive Stage Small Cell Lung Cancer in Korea
09:30 - 09:30 | Presenter: Jung Sun Kim | Author(s): Y.J. Choi, E.J. Kang
- Abstract
Loading... -
+
P1.15-013 - Small Cell Lung Cancer. Methodology and Preliminary Results from the Small Cell Study
09:30 - 09:30 | Presenter: Ángeles Rodríguez | Author(s): A. Ruano-Ravina, M. Constenla Figueiras, M. Torres Duran
- Abstract
Loading... -
+
P1.15-014 - Can Limited Resection Be Accepted as an Alternative Treatment Option for Patients with Early-Stage Small Cell Lung Cancer?
09:30 - 09:30 | Presenter: Takamasa Koga | Author(s): I. Kubota, F. Kosuke, M. Sanada, Y. Motooka, K. Yoshimoto, K. Shiraishi, K. Ikeda, J. Wakimoto, Takeshi Mori, M. Suzuki
- Abstract
Loading... -
+
P1.15-015 - Prognostic Implication of the FEV1/FVC Ratio in Limited-Stage Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Young-Taek Oh | Author(s): O. Cho, M. Chun, O.K. Noh, J. Heo
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.15-017 - Adoption of Prophylactic Cranial Irradiation for Extensive Stage Small Cell Lung Cancer: A Population Based Outcomes Study
09:30 - 09:30 | Presenter: Swee Peng Yap | Author(s): Y.Y. Soon, H. Zheng, S. Ho, Wee Yao Koh, C.N. Leong, B. Vellayappan, J. Tey, K.W. Fong, Ivan WK Tham
- Abstract
Loading...
-
+
P1.16 - Surgery
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Surgery
-
+
P1.16-001 - Characteristics of Resected Lung Cancer in Patients Aged under 60: A Single–Center Experience
09:30 - 09:30 | Presenter: Jeong Su Cho | Author(s): Y.D. Kim, H.Y. Ahn, H. I, J. Son
- Abstract
Loading... -
+
P1.16-002 - Management of Local Recurrence after Segmentectomy for Stage IA Lung Cancer
09:30 - 09:30 | Presenter: Takeshi Mori | Author(s): F. Kosuke, T. Yamada, H. Osumi, Y. Motooka, E. Matsubara, K. Shiraishi, K. Ikeda, M. Suzuki
- Abstract
Loading... -
+
P1.16-003 - Learning Curve for Adoption of Robotic Lobectomy for Early Stage Non-Small Cell Lung Cancer by a Thoracic Surgeon Experienced in Open Lobectomy
09:30 - 09:30 | Presenter: Shea Gallagher | Author(s): A. Abolhoda, V. Kirkpatrick, A. Saffarzadeh, M. Thein, S. Wilson
- Abstract
Loading... -
+
P1.16-004 - Intubated Versus Non-intubated Anesthesia for Lung Cancer VATS in Octogenerians
09:30 - 09:30 | Presenter: Nenad Ilic | Author(s): D. Ilic, J. Juricic, D. Krnic, D. Orsulic, I. Simundza, N. Frleta Ilic
- Abstract
Loading... -
+
P1.16-005 - Comparison Sublobar vs Lobar Resection in Early Stage Lung Cancer in Octagenarian Patients
09:30 - 09:30 | Presenter: Sira Laohathai
- Abstract
Loading... -
+
P1.16-006 - Less Is More: video Assisted Thoracic Surgery (VATS) vs Open Thoracotomy in the Management of Resectable Lung Cancer
09:30 - 09:30 | Presenter: Shagufta Shaheen | Author(s): B. Jabo, M. Kaur, M. Senthil, S. Mirshahidi, S. Zaheer, H.R. Mirshahidi
- Abstract
Loading... -
+
P1.16-007 - Mobile Computed Tomography in Video-Assisted Thoracoscopic Surgery for Ground-Glass Opacity Lung Nodules
09:30 - 09:30 | Presenter: Kouhei Tajima | Author(s): E. Yamaki, A. Mogi, H. Kuwano
- Abstract
Loading... -
+
P1.16-008 - Near-Infrared Fluorescence-Guided Pulmonary Segmentectomy Following Endobronchial Indocyanine Green Injection
09:30 - 09:30 | Presenter: Hironobu Wada | Author(s): H. Oheda, K. Nishii, T. Kaiho, K. Ohashi, Y. Shina, Y. Sata, T. Toyoda, A. Hata, Yuichi Sakairi, H. Tamura, T. Fujiwara, Takahiro Nakajima, H. Suzuki, M. Chiyo, I. Yoshino
- Abstract
Loading... -
+
P1.16-009 - Comparing Lymph Node Dissection in VATS versus Open Lung Cancer Surgery: How, How Long, and How Does It Matter?
09:30 - 09:30 | Presenter: Alan D L Sihoe | Author(s): E. Yeung
- Abstract
Loading... -
+
P1.16-010 - Development of a Novel Surgical Marking Method Using Low Power Laser Light
09:30 - 09:30 | Presenter: Keishi Ohtani | Author(s): S. Maehara, K. Imai, H. Furumoto, M. Hagiwara, T. Okano, Masatoshi Kakihana, Naohiro Kajiwara, T. Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
P1.16-011 - The Role of 3D-CT in Patients with Pulmonary Malignancies Undergoing Segmentectomy
09:30 - 09:30 | Presenter: Ali Amiraliev | Author(s): Oleg Pikin, A. Ryabov, N. Rubtsova, A. Khalimon, D. Vursol, V. Barmin, O. Alexandrov, N. Epifanov
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.16-013 - Video-Assisted Thoracoscopic Surgery (VATS) versus Thoracotomy in Locally-Advanced Lung Cancers – a Meta-Analysis
09:30 - 09:30 | Presenter: Gerald Sng | Author(s): C. Ng
- Abstract
Loading... -
+
P1.16-014 - The Efficacy of Thoracoscopic Right Upper Lobectomy Using Fissureless Technique in Patients with Dense Fissures
09:30 - 09:30 | Presenter: Hitoshi Igai | Author(s): M. Kamiyoshihara, Ryohei Yoshikawa, F. Osawa, Takashi Ibe
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.16-016 - Comparing Safety and Effectiveness of Image-Guided VATS Versus Conventional VATS for Small or Deep Pulmonary Nodules
09:30 - 09:30 | Presenter: Yin Kai Chao
- Abstract
Loading... -
+
P1.16-017 - Middle Term Survival Outcome of Single Port Video Assisted Thoracoscopic Anatomic Lung Resection: Two Center Experience
09:30 - 09:30 | Presenter: Ching Feng Wu | Author(s): M. De La Torre, R. Fernandez, M. Delgado, E. Fieira, Ching-Yang Wu, M. Hsieh, M. Paradela, Y. Liu, D. Gonzalez-Rivas
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.16-019 - Three Dimensional CT Angio-Bronchography Doesn't Contribute to the Shortening of the Operation Time in Segmentectomy
09:30 - 09:30 | Presenter: Hirohisa Horinouchi | Author(s): F. Maitani, S. Miyabe
- Abstract
Loading... -
+
P1.16-020 - Outcomes of Pulmonary Metastasectomy in Hepatocellular Carcinoma According to Approach Method-Thoracoscopic Versus Open Approach
09:30 - 09:30 | Presenter: Hyeong Ryul Kim | Author(s): H.P. Lee, D.K. Kim, Y. Kim, S. Park
- Abstract
Loading... -
+
P1.16-021 - Midterm Oncologic Outcomes of Single Port Thoracoscopic Lobectomy for Lung Cancer by Propensity Matched Analysis
09:30 - 09:30 | Presenter: Kook Nam Han | Author(s): H.K. Kim, Y.H. Choi
- Abstract
Loading... -
+
P1.16-022 - Incorporating Robotics to the Surgical Treatment of Thoracic Neoplasms: 5-Year Experience at an Academic Center
09:30 - 09:30 | Presenter: Dao Minh Nguyen | Author(s): N.R. Villamizar, J.A. Stephens-Mcdonough, R.J. Thurer, T. Baxter
- Abstract
Loading... -
+
P1.16-023 - A Useful and Safe Method of Intraoperative Localization of Small-Sized Peripheral Pulmonary Lesions
09:30 - 09:30 | Presenter: Yujiro Kubo | Author(s): Mototsugu Watanabe, K. Kataoka
- Abstract
Loading... -
+
P1.16-024 - A Case of Bronchial Atresia Treated with Complete Thoracoscopy-Assisted Right S6 Segmentectomy Using Fluorescence Navigation
09:30 - 09:30 | Presenter: Mototsugu Watanabe | Author(s): Yujiro Kubo, T. Shiotani, K. Kataoka
- Abstract
Loading... -
+
P1.16-025 - Safety of Simultaneous TEVAR and Combined Aortic Wall Resection at the Time of Lung Resection for T4 Lung Cancer Infiltrating the Aorta
09:30 - 09:30 | Presenter: Masanori Tsuchida | Author(s): Terumoto Koike, S. Sato, Tatsuya Goto, A. Kitahara, A. Nakamura
- Abstract
Loading... -
+
P1.16-026 - Multimodal Image-Guided VATS Resection of Sub-Centimeter Pulmonary Nodules by Cone Beam CT and Bronchoscopic NIR Fluorescence Marking
09:30 - 09:30 | Presenter: Takashi Anayama | Author(s): Kentaro Hirohashi, H. Okada, N. Kawamoto, R. Miyazaki, M. Yamamoto, M. Kume, K. Orihashi
- Abstract
Loading... -
+
P1.16-027 - Robotic Surgery, VATS, and Open Surgery for Early Stage Lung Cancer: Comparison of Costs and Outcomes at a Single Institute
09:30 - 09:30 | Presenter: Pierluigi Novellis | Author(s): E. Bottoni, E. Voulaz, U. Cariboni, A. Testori, L. Giordano, E. Dieci, L. Granato, E. Vanni, M. Montorsi, M. Alloisio, Giulia Veronesi
- Abstract
Loading... -
+
P1.16-028 - Is Video-Assisted Thoracic Surgery a Safer Procedure for Lung Cancer Patients?
09:30 - 09:30 | Presenter: Maria Teresa Ruiz Tsukazan | Author(s): R.M. Terra, A. Vigo, G. Fortunato, S. Camargo, H. Oliveira, D. Pinto Filho
- Abstract
Loading...
-
+
P1.17 - Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
-
+
- Abstract
Loading... -
+
P1.17-002 - Clinicopathological Significance of Epithelial Mesenchymal Transition in Thymic Cancer
09:30 - 09:30 | Presenter: Yasushi Shintani | Author(s): S. Funaki, T. Kawamura, N. Ose, Ryu Kanzaki, Kenji Kimura, Y. Yamamoto, M. Minami, Meinoshin Okumura
- Abstract
Loading... -
+
P1.17-003 - Identification of Differentially Expressed Genes between Thymoma and Paraneoplastic Thymic Tissue
09:30 - 09:30 | Presenter: Lei Yu
- Abstract
Loading... -
+
P1.17-004 - Extrapleural Pneumonectomy for Patients with Stage IVa Thymoma: Pathological Evaluation of Disseminated Pleural Nodules
09:30 - 09:30 | Presenter: Shota Nakamura | Author(s): H. Tateyama, K. Kawaguchi, T. Fukui, S. Hakiri, N. Ozeki, T. Kato, K. Yokoi
- Abstract
Loading... -
+
P1.17-005 - Pure Red Cell Aplasia Associated with Thymoma: A Report of a Single-Center Experience
09:30 - 09:30 | Presenter: Satoru Moriyama | Author(s): H. Haneda, Katsuhiro Okuda, O. Kawano, T. Sakane, R. Oda, T. Watanabe, M. Yano, R. Nakanishi
- Abstract
Loading... -
+
P1.17-006 - Radiographic Assessment for Tumor Responses of Thymic Carcinoma Using the ITMIG Modified Criteria
09:30 - 09:30 | Presenter: Taiki Hakozaki | Author(s): Y. Okuma, Y. Hosomi
- Abstract
Loading... -
+
P1.17-008 - Clinical and Oncological Outcomes on Resected Thymomas over a Decade at the National Cancer Institute at Mexico City
09:30 - 09:30 | Presenter: Francisco Corona Cruz | Author(s): R.A. López Saucedo, E. Jiménez Fuentes, J. De La Garza, Oscar Arrieta, M. Moscoso Fernández Salvador, J.A. González Luna
- Abstract
Loading... -
+
P1.17-009 - Clinical Significance of Preoperative Neutrophil-Lymphocyte Ratio in Patients with Thymic Epithelial Tumor Undergoing Surgery
09:30 - 09:30 | Presenter: Satoru Okada | Author(s): S. Ishihara, N. Ishikawa, T. Furuya, C. Nakazono, Naoko Miyata, H. Tsunezuka, D. Kato, Junichi Shimada, M. Inoue
- Abstract
Loading... -
+
P1.17-010 - The Diagnostic Value of Serum Cytokeratin Fragment 19 (CYFRA21-1) for Thymic Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Haruhiko Shiiya | Author(s): Yasuhiro Hida, K. Kaga, T. Kato, M. Aragaki, R.N. Kubota, Y. Matsui
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.17-012 - Thymic Neoplasms: The Experience of a Cancer Institute
09:30 - 09:30 | Presenter: Rita Vitorino | Author(s): M. Reis, C. Travancinha, P. Ferreira, N. Abecassis, D. Da Costa, T. Almodovar
- Abstract
Loading... -
+
P1.17-013 - Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
09:30 - 09:30 | Presenter: Soichiro Funaki | Author(s): Yasushi Shintani, N. Ose, T. Kawamura, Ryu Kanzaki, M. Minami, Meinoshin Okumura
- Abstract
Loading... -
+
P1.17-014 - Platinum Rechallenge in Advanced Thymic Epithelial Tumors: Still an Option in the Age of Target Therapy? A Monocentric Experience
09:30 - 09:30 | Presenter: Margaret Ottaviano | Author(s): V. Damiano, P. Perrone, M. Capuano, M. Tortora, C. Forino, G. Palmieri
- Abstract
Loading... -
+
P1.17-015 - Long Acting Octreotide plus Prednisone in Advanced Thymic Epithelial Tumors: A Real Life Clinical Experience
09:30 - 09:30 | Presenter: Margaret Ottaviano | Author(s): V. Damiano, M. Tortora, M. Capuano, P. Perrone, C. Forino, E. Matano, G. Palmieri
- Abstract
Loading... -
+
P1.17-016 - Immunohistochemical Markers as Prognostic Factors in Malignant Thymic Epithelial Tumors
09:30 - 09:30 | Presenter: Yoshito Yamada | Author(s): P. Leisibach, D. Schneiter, A. Soltermann, Walter Weder, W. Jungraithmayr
- Abstract
Loading... -
+
P1.17-017 - Usefulness of FDG-PET for Differentiating Thymic Epithelial Tumors from Malignant Lymphomas
09:30 - 09:30 | Presenter: Hiroyuki Sakamaki | Author(s): T. Otsuka, M. Suzuki, S. Omura, H. Tanaka, Yota Suzuki, S. Kuriyama, K. Hamada, Masaya Yotsukura, Kaoru Kaseda, K. Masai, T. Hishida, Hisao Asamura
- Abstract
Loading... -
+
P1.17-018 - Distribution of Ectopic Thymus in Chinese Patients: A Preliminary Study
09:30 - 09:30 | Presenter: Jian-Yong Ding | Author(s): C. Jin, M. Yao
- Abstract
Loading... -
+
P1.17-019 - B7-H3 Protein Expression in Thymic Epithelial Tumour Subtypes and Its Association with PD-L1 and Clinical Characteristics
09:30 - 09:30 | Presenter: Spyridon Gennatas | Author(s): A. Mandal, J.L. Robertus, A. Bowman, Andrew G Nicholson, Sanjay Popat, A.M. Bowcock
- Abstract
Loading... -
+
P1.17-019a - Pathological Discrepancies in the Diagnosis of Thymic Malignancies: The Tallinn-Lyon Experience
09:30 - 09:30 | Presenter: K. Oselin | Author(s): Nicolas Girard, A. Adamsom, K. Lepik, T. Vanakesa, I. Almre, T. Leismann, L. Chalabreysse
- Abstract
Loading... -
+
P1.17-019b - Acute and Late Toxicities in the Management of Malignant Thymomas After Subtotal Resection, Chemotherapy and Radiotherapy
09:30 - 09:30 | Presenter: Jan Stejskal | Author(s): M. Kubecová, D. Dvorakova, V. Ulrych, J. Vanasek
- Abstract
Loading...
-
+
ES 01 - New TNM and WHO Classification
- 11:00 - 12:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Educational Session
- Track: Radiology/Staging/Screening
- Moderators:M. Noguchi, Peter Goldstraw
-
+
ES 01.01 - New TNM Classification
11:00 - 11:20 | Presenter: Ramon Rami-Porta
- Abstract
Loading... -
+
ES 01.02 - New Histological Classification
11:20 - 11:40 | Presenter: William D Travis
- Abstract
Loading... -
+
ES 01.03 - Immunohistochemistry, Chromosomal and DNA Analysis, and Molecular Testing
11:40 - 12:00 | Presenter: Yasushi Yatabe
- Abstract
No abstract available for this presentation
-
+
ES 01.04 - Staging and Pathology of Multiple Nodules Presenting in the Lungs
12:00 - 12:20 | Presenter: Andrew G Nicholson
- Abstract
Loading... -
+
ES 01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES 02 - Diagnostic and Interventional Radiology in Lung Cancer: Update 2017
- 11:00 - 12:30
- 10/16/2017
- Location: Room 315
- Type: Educational Session
- Track: Radiology/Staging/Screening
- Moderators:David F Yankelevitz, Shuji Sakai
-
+
ES 02.01 - The Dutch-Belgian Lung Cancer Screening Trial (NELSON)
11:00 - 11:15 | Presenter: Harry J De Koning
- Abstract
Loading... -
+
ES 02.02 - The Fleischner Guideline / Lung-RADs
11:15 - 11:30 | Presenter: Matthew Eric Callister
- Abstract
Loading... -
+
ES 02.03 - Radiologic Implications of the WHO Classification for Lung Cancer
11:30 - 11:45 | Presenter: Kavita Garg
- Abstract
Loading... -
+
ES 02.04 - Interventional Radiology on Personalized Medicine for Lung Cancer
11:45 - 12:00 | Presenter: Tae Jung Kim
- Abstract
Loading... -
+
ES 02.05 - MRI and Advanced Applications for Lung Cancer
12:00 - 12:15 | Presenter: Yoshiharu Ohno
- Abstract
Loading... -
+
ES 02.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
GR 01 - What to Do at the Time of Progression on Targeted Therapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Grand Rounds
- Track: Chemotherapy/Targeted Therapy
- Moderators:D. Kim, Lecia V Sequist
-
+
GR 01.01 - Case Study
11:00 - 11:05 | Presenter: D. Kim
- Abstract
No abstract available for this presentation
-
+
GR 01.02 - Case Study
11:05 - 11:10 | Presenter: Lecia V Sequist
- Abstract
No abstract available for this presentation
-
+
GR 01.03 - First-Line Management of EGFR Mutant NSCLC
11:10 - 11:30 | Presenter: Li Zhang
- Abstract
Loading... -
+
GR 01.04 - EGFR-Positive NSCLC Cases Who Failed Previous EGFR-TKI
11:30 - 11:50 | Presenter: Gregory J Riely
- Abstract
No abstract available for this presentation
-
+
GR 01.05 - First-Line Management of ALK Mutant NSCLC
11:50 - 12:10 | Presenter: Silvia Novello | Author(s): C. Mecca
- Abstract
Loading... -
+
GR 01.06 - ALK-Positive NSCLC Cases who Failed Previous ALK Inhibitors
12:10 - 12:30 | Presenter: Jürgen Wolf
- Abstract
No abstract available for this presentation
-
+
MA 01 - SCLC: Research Perspectives
- 11:00 - 12:30
- 10/16/2017
- Location: Room 503
- Type: Mini Oral
- Track: SCLC/Neuroendocrine Tumors
- Moderators:John V Heymach, Eun Kyung Cho
-
+
MA 01.01 - Metastatic Behavior of Pulmonary Neuroendocrine Carcinomas Is Associated with Epithelial to Mesenchymal Transition Gene Profile
11:00 - 11:05 | Presenter: Tabatha Gutierrez Prieto | Author(s): Vanessa Karen De Sá, E.H.R. Olivieri, E.C.A. Da Silva, R.M. Reis, D.M. Carraro, Vera Luiza Capelozzi
- Abstract
Loading... -
+
MA 01.02 - Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers Versus Heavy Smokers
11:05 - 11:10 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, L. Rojas, Z.L. Zatarain-Barron, L. Corrales, Claudio Martin, J. Rodriguez, J. Rodriguez, P. Archila, Alejandro Ruiz-Patiño, Rafael Rosell
- Abstract
Loading... -
+
MA 01.03 - The Potential of ctDNA Sequencing in Disease Monitoring and Depicting Genomic Evolution of Small-Cell Lung Cancer Under Therapy
11:10 - 11:15 | Presenter: Vincent K Lam | Author(s): J. Wang, Y. Gong, J. Nong, Y. Yi, Y. Guan, L. Yang, H. Jia, S. Zhang, X. Yi, Z. Liao, Vassiliki A Papadimitrakopoulou, Ignacio I. Wistuba, John V Heymach, B. Glisson, A. Futreal, X. Xia, Jianjun Zhang
- Abstract
Loading... -
+
MA 01.04 - Discussant - MA 01.01, MA 01.02, MA 01.03
11:15 - 11:30 | Presenter: Charles Andrew Butts
- Abstract
No abstract available for this presentation
-
+
MA 01.05 - Activity and Safety of the Combination of PM01183 and Doxorubicin in Relapsed SCLC. Final Results of a Phase Ib Trial
11:30 - 11:35 | Presenter: Emiliano Calvo | Author(s): M. Forster, V. Moreno, M.E. Olmedo, M.P. Lopez Criado, Jose Antonio Lopez-Vilariño, C. Kahatt, A. Soto-Matos
- Abstract
Loading... -
+
MA 01.06 - A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Chemotherapy-Resistant Small Cell Lung Cancer
11:35 - 11:40 | Presenter: Hongbin Chen | Author(s): Grace K Dy, A. Groman, E. Farrell, A. Miller, P. Bushunow, Alex Adjei
- Abstract
Loading... -
+
MA 01.07 - Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 Trial
11:40 - 11:45 | Presenter: Sara Pilotto | Author(s): E. Bria, Domenico Galetta, Francesco Grossi, G. Fasola, G. Romano, L. Bonanno, A. Bearz, M. Papi, A. Caprioli, A. Catino, A. Follador, E. Rijavec, A. Misino, G. Surico, A. Favaretto, L. Giannone, G. Tortora, D. Giannarelli, A. Santo
- Abstract
Loading... -
+
MA 01.08 - Discussant - MA 01.05, MA 01.06, MA 01.07
11:45 - 12:00 | Presenter: Anne Tsao
- Abstract
No abstract available for this presentation
-
+
MA 01.09 - Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan
12:00 - 12:05 | Presenter: Yong Yuan | Author(s): K. Higginbottom, M. Dibonaventura, J.R. Penrod
- Abstract
Loading... -
+
MA 01.10 - Outcome Based on Baseline Total Lymphocyte Count & Neutrophil-To-Lymphocyte Ratio in Extensive Stage Small-Cell Lung Cancer
12:05 - 12:10 | Presenter: Ryoko Suzuki | Author(s): S.H. Lin, X. Wei, P.K. Allen, J.W. Welsh, L.A. Byers, Ritsuko Komaki
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 01.12 - Discussant - MA 01.09, MA 01.10, MA 01.11
12:15 - 12:30 | Presenter: Anand Swaminath
- Abstract
No abstract available for this presentation
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.01 - Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitors
11:00 - 11:05 | Presenter: Ticiana A. Leal | Author(s): T. Campbell, A. Mapes, K. Schneider, M.J. Staab, K. Velastegui, J.G. Christensen, I. Chen, A. Traynor
- Abstract
Loading... -
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Presenter: Luis Paz-Ares | Author(s): B.P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Marina Chiara Garassino, M. Domine, Pilar Garrido, B. Piperdi, S. Ponce Aix, R. Slepetis, X. Wu, A. Fandi
- Abstract
Loading... -
+
MA 02.03 - Selective Histone Deacetylase Inhibitor ACY-241 Plus Nivolumab for Refractory Advanced NSCLC: Results From a Phase 1b Study
11:10 - 11:15 | Presenter: Mark Awad | Author(s): Y. Le Bruchec, R. Markelewicz, P. Chen, A. Fandi, A. Spira
- Abstract
Loading... -
+
MA 02.04 - Discussant - MA 02.01, MA 02.02, MA 02.03
11:15 - 11:30 | Presenter: Grace K Dy
- Abstract
No abstract available for this presentation
-
+
MA 02.05 - Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)
11:30 - 11:35 | Presenter: Domenico Galetta | Author(s): A. Ardizzoni, P. Bidoli, R. Chiari, L. Bonomi, D. Turci, L. Landi, L. Toschi, M. De Tursi, G. Francini, M. Giordano, O. Alabiso, A. De Censi, L. Livi, A. Berruti, M. Minelli, E. Ricevuto, A. Illiano, G. Puppo, A. Delmonte
- Abstract
Loading... -
+
MA 02.06 - BRAF Mutant NSCLC: Correlation with PD-L1 Expression,TMB, MSI and Response to ICPi and Anti-BRAF Therapy
11:35 - 11:40 | Presenter: Elizabeth Dudnik | Author(s): Nir Peled, M. Wollner, Amir Onn, A. Agbareya, H. Nechushtan, T. Kuznetsov, L.C. Roisman, A. Belilovski Rozenblum, Smadar Geva, A. Zer, Jair Bar
- Abstract
Loading... -
+
MA 02.07 - A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
11:40 - 11:45 | Presenter: Aaron Lisberg | Author(s): J. Hunt, N. Reese, T. Wang, P. Coluzzi, M. Spiegel, K. Bornazyan, J. Carroll, J. Madrigal, B. Ledezma, M. Mendenhall, J.L. Bui, H. Lu, A. Cummings, Z. Noor, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading... -
+
MA 02.08 - Discussant - MA 02.05, MA 02.06, MA 02.07
11:45 - 12:00 | Presenter: Barbara Melosky
- Abstract
No abstract available for this presentation
-
+
MA 02.09 - A Ph I/II Study of BGB324, a Selective AXL Inhibitor as Monotherapy and in Combination with Erlotinib in Advanced NSCLC
12:00 - 12:05 | Presenter: Don Lynn Gibbons | Author(s): L. Byers, David E Gerber, J. Peguero, D. Micklem, M. Yule, J. Lorens
- Abstract
Loading... -
+
MA 02.10 - Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC
12:05 - 12:10 | Presenter: Jonathan Wade Goldman | Author(s): E. Angevin, J. Strickler, D. Ross Camidge, R. Heist, D. Morgensztern, M. Barve, H. Yue, J. Beaulieu, M. Motwani, D. Afar, L. Naumovski, Karen Kelly
- Abstract
Loading... -
+
MA 02.11 - A Phase I Trial of Erlotinib and Onalespib in EGFR-mutant NSCLC: Focus on EGFR Exon 20 Insertions
12:10 - 12:15 | Presenter: Jonathan W Riess | Author(s): Karen L Reckamp, J. Longmate, Karen Kelly, David R. Gandara, Philip Christopher Mack, E. Newman, Primo Lara
- Abstract
Loading... -
+
MA 02.12 - Discussant - MA 02.09, MA 02.10, MA 02.11
12:15 - 12:30 | Presenter: Dean A Fennell
- Abstract
No abstract available for this presentation